◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

ホーム全銘柄 › GL · English version

Globe Life Inc (GL)

公式財務諸表に基づく売上高、利益、キャッシュフローの推移。

Financials · ウォール街(米国) · 最終更新: 2026-08-16

Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products to lower middle- and middle-income families in the United States. It operates in three segments: Life Insurance, Supplemental Health Insurance, and Investments.

主要指標

インタラクティブチャートと全財務諸表を見る → バリュエーションモデル(DCF)→

年次損益計算書

損益計算書TTM → 2026-03-312025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
売上高合計$6.1B$6.0B$5.8B$5.4B$5.2B$5.1B$4.7B$4.5B$4.3B$4.2B$3.9B$3.8B$4.0B$3.5B$3.6B$3.4B$3.4B$3.2B$3.3B$3.5B$3.4B
売上総利益$2.3B$2.0B$1.9B$1.6B$4.9B$4.8B$4.4B$4.2B$4.0B$3.9B$1.1B$1.1B$3.7B$1.0B$1.0B$1.0B$1.0B$3.0B$3.1B$1.2B$1.2B
売上総利益率 %38.1%33.4%32.4%30.1%93.2%93.7%93.7%93.3%93.5%93.8%27.6%28.3%94.4%30.0%29.1%29.7%29.8%94.6%94.4%34.2%34.5%
営業利益(EBIT)$1.5B$1.5B$1.3B$1.2B$997M$911M$895M$930M$954M$924M$772M$766M$855M$755M$766M$724M$751M$675M$724M$797M$774M
営業利益率 %24.9%24.4%23.0%21.9%19.1%17.8%18.9%20.5%22.2%22.2%19.6%20.3%21.6%21.6%21.3%21.4%22.3%20.9%21.8%22.9%22.6%
当期純利益$1.2B$1.2B$1.1B$971M$740M$745M$732M$761M$701M$1.5B$550M$527M$543M$528M$529M$497M$499M$405M$452M$528M$519M
純利益率 %19.4%19.4%18.5%17.8%14.2%14.6%15.4%16.8%16.3%35.0%14.0%14.0%13.7%15.1%14.8%14.7%14.8%12.6%13.6%15.1%15.2%
EBITDA$1.6B$1.6B$1.5B$1.3B$997M$911M$895M$930M$954M$915M$856M$843M$855M$836M$847M$802M$826M$675M$724M$1.3B$1.2B
1株当たり利益(EPS)$14.46$14.36$12.63$10.07$7.47$7.22$6.82$6.83$6.08$12.22$4.49$4.16$4.09$3.79$3.60$3.02$2.70$2.17$2.27$2.45$2.28
発行済株式数(百万株)80M81M85M96M99M103M107M111M115M119M122M127M133M140M147M165M185M187M199M216M227M

出典: 企業の公開資料(SEC)。数値をご利用の前に SEC EDGAR でご確認ください。

貸借対照表、キャッシュフロー計算書、四半期データおよび全財務比率は GL のインタラクティブ・ビューアーでご覧いただけます。 /companies/us/GL

類似企業

本サイトの情報は教育および情報提供のみを目的としており、投資助言ではありません。目標株価や投資判断は掲載していません。

English version →全銘柄

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.